Home › Heart Attack › North Carolina › Durham
Heart Attack clinical trials in Durham, NC
3 studies for Heart Attack are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RecruitingPhase 3
- Duke Regional Hospital, Durham
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Durham Nephrology Associates, PA, Durham
- Duke Translational Medicine Institute, Durham
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- Duke University Health System, Durham
About Heart Attack
A heart attack happens when the blood flow to the heart gets blocked. It causes heart damage and is a medical emergency. Know the symptoms and when to call 911.
More about Heart Attack on MedlinePlus
Heart Attack trials in other cities
- Rochester, MN6 studies
- New York City, NY6 studies
- Dallas, TX5 studies
- Boston, MA5 studies
- Knoxville, TN3 studies
- Houston, TX3 studies
- Hartford, CT3 studies
- Greensboro, NC3 studies
- Los Angeles, CA3 studies
- Nashville, TN3 studies
- Detroit, MI3 studies
- Minneapolis, MN3 studies
Other studies in Durham
- Breast Cancer63 studies
- Cancer (all types)61 studies
- Non-Small Cell Lung Cancer42 studies
- Multiple Myeloma36 studies
- Acute Myeloid Leukemia34 studies
- Lung Cancer33 studies
- Metastatic Cancer33 studies
- Prostate Cancer32 studies
- Colorectal Cancer30 studies
- Ovarian Cancer28 studies
- Chronic Lymphocytic Leukemia28 studies
- Heart Failure25 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.